Pliant Therapeutics, Inc. (PLRX)
1.205
-0.02
(-1.23%)
USD |
NASDAQ |
May 11, 16:00
1.205
0.00 (0.00%)
After-Hours: 20:00
Pliant Therapeutics Total Assets (Quarterly) : 230.57M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 1.422B |
| Corcept Therapeutics, Inc. | 814.88M |
| Assertio Holdings, Inc. | 211.30M |
| Veru, Inc. | 47.57M |
| IGC Pharma, Inc. | 9.712M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 49.36M |
| Shareholders Equity (Quarterly) | 181.20M |
| Debt to Equity Ratio | 0.1606 |
| Current Ratio | 12.00 |
| Net Debt Paydown Yield | 8.30% |